Leaflet: information for the user
Water for injectable preparations Bexen solvent for parenteral use
Read this leaflet carefully before you start using this medicine, because it contains important information for you.
Bexen Injectable Water for Preparations is used as a solvent and vehicle for medications that must be administered parenterally, that is, by intravenous injection.
Do not use
Bexen Injectable Diluent by itself via intravenous route.
Warnings and precautions
Consult your doctor, pharmacist, or nurse before starting to use Bexen Injectable Diluent:
Use of Bexen Injectable Diluent with other medications
Inform your doctor or pharmacist that you are using, have recently used, or may need to use any other medication.
Bexen Injectable Diluent is only incompatible with those medications that are insoluble in water.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or intend to become pregnant, consult your doctor or pharmacist before using this medication.
Follow exactly the administration instructions for this medication as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
The recommended dose depends on the medication to be dissolved in water for injectable preparations.
If you use more Water for injectable preparations Bexen than you should
In case of overdose, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone: 91 562 04 20, indicating the medication used.
If you use more Water for injectable preparations Bexen than you should, hemolysis (rupture of red blood cells) may occur.
If you have any other questions about the use of this medication, ask your doctor, pharmacist, or nurse.
Like all medications, Bexen Injectable Preparation Water may produce adverse effects, although not everyone will experience them.
It is not expected that adverse reactions will occur if used correctly.
The intravenous administration of Bexen Injectable Preparation Water may cause hemolysis (destruction of red blood cells) if administered alone.
If you experience adverse effects, consult your doctor, pharmacist, or nurse, even if they are not listed in this prospectus.
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor, pharmacist, or nurse, even if they are not listed in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicinal Products for Human Use:https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information about the safety of this medication.
No special storage conditions are required.
Do not use if the container shows visible signs of deterioration.
Keep this medication out of the sight and reach of children.
Dispose of any residual content that may have remained once the container is opened.
Do not use this medication after the expiration date that appears on the container after CAD. The expiration date is the last day of the month indicated.
Medications should not be disposed of through drains or in the trash. Deposit containers and medications you no longer need at the SIGRE point of your pharmacy. If in doubt, ask your pharmacist how to dispose of containers and medications you no longer need. By doing so, you will help protect the environment.
Composition of Water for Injections Bexen
The active ingredient is water for injections. Each ampoule contains 5ml of water for injections.
Appearance of the product and contents of the packaging
Water for injections Bexen is a transparent and colorless solution, presented in 5ml polyethylene ampoules of water for injections.
Packaging size: 1 pack of 5ml.
Holder of the marketing authorization and manufacturer responsible
Holder of the marketing authorization
OIARSO COOPERATIVE SOCIETY
Zikuñaga 57-F. Industrial Estate Ibarluze.
20128 Hernani (Guipúzcoa)
Manufacturer responsible
B. Braun Medical, S.A
Terrassa Road, 121
08191. Rubí (Barcelona)
Last review date of this leaflet: March 1998
The detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.